Advertisement

Non-AIDS-Defining Malignancies

  • Phoebe Trubowitz
  • Amy Gates
  • Lawrence Kaplan
Part of the Cancer Treatment and Research book series (CTAR, volume 104)

Abstract

Malignancies in the setting of immunodeficiency have been well described in the literature long before the advent of the HIV epidemic.1-3. The incidence of malignancy is significantly increased in the setting of abnormal cell-mediated immunity1,3,4This increase in incidence, however, does not apply to those cancers most commonly seen in the general population. Rather, it is a narrow spectrum of more unusual tumors that are observed in these immunosuppressed individuals such as Kaposi’s sarcoma and non-Hodgkin’s lymphoma (NHL)3,4.

Keywords

Human Immunodeficiency Virus Multiple Myeloma Basal Cell Carcinoma Anal Cancer Receptive Anal Intercourse 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Frizzera G, Rosai J, Dehner L, et al. Lymphoreticular disorders in primary immunodeficiencies: New findings based on an up-to-date histologic classification of 35 cases. Cancer 1980; 46:692–699.PubMedCrossRefGoogle Scholar
  2. 2.
    Harwood A, Osoba D, Hofstader S, et al. Kaposi’s sarcoma in recipients of renal transplants. Am J Med 1979; 67:759–765.PubMedCrossRefGoogle Scholar
  3. 3.
    Hoover R, Fraumeni J. Risk of cancer in renal transplant recipients. Lancet 1973; 2:55–57.PubMedCrossRefGoogle Scholar
  4. 4.
    Penn I. The incidence of malignancies in transplant recipients. Transplant Proc 1975; 7:323–326.PubMedGoogle Scholar
  5. 5.
    Biggar RJ, Rabkin CS. The epidemiology of AIDS-related neoplasms. Hematology/Oncology Clinics of North America 1996; 10:997–1010.PubMedCrossRefGoogle Scholar
  6. 6.
    Biggar, RJ. Epidemiologic clues to the etiology of cancer in AIDS. In abstracts of the 2nd National AIDS Malignancy Conference, Bethesda, MD, 1998, Abstract S2.Google Scholar
  7. 7.
    Lyter DW, Bryant J, Thackeray R, Rinaldo CR, Kingsley LA. Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men. Journal of Clinical Oncology 1995; 13:2540–2546.PubMedGoogle Scholar
  8. 8.
    Remick S. Non-AIDS-defining cancers. Hematol Oncol Clin North Am 1996; 10:1203–1213.PubMedCrossRefGoogle Scholar
  9. 9.
    Volm M, Von Roenn J. Non-AIDS-defining malignancies in patients with HIV infection. Cuff Opin Oncol 1996; 8:386–391.CrossRefGoogle Scholar
  10. 10.
    Ravalli S, Chabon A, Khan A. Gastrointestinal neoplasia in young HIV-positive patients. Am J Clin Pathol 1989; 91:458–461.PubMedGoogle Scholar
  11. 11.
    Tirelli U, Vaccher E, Sinicco A, et al. Forty-nine unusual HIV-related malignant tumors. Program of the 5th International Conference on AIDS, Montreal, Canada, 1989.Google Scholar
  12. 12.
    Goedert JJ, et al. Spectrum of AIDS-associated malignant disorders. Lancet 1998; 351:1833–1839.PubMedCrossRefGoogle Scholar
  13. 13.
    Rabkin CS. Association of non-acquired immunodeficiency syndrome-defining cancers with human immunodeficiency virus infection. Journal of the National Cancer Institute. Monographs, 1998(23):23–5.Google Scholar
  14. 14.
    Timmerman J, Northfelt D, Small E. Malignant germ cell tumors in men infected with human immunodeficiency virus: Natural history and results of therapy. J Clin Oncol 1996; 13:1391–1397.Google Scholar
  15. 15.
    Bernardi et al. Testicular germ cell tumors and human immunodeficiency virus infection: a report of 26 cases. Italian Cooperative Group on AIDS and Tumors. J Clin Oncol 13:2705–2711.Google Scholar
  16. 16.
    Berry, J. and J. Palefsky, Pathogenesis and Clinical Manifestations of HIV-Associated Anogenital Neoplasia. AIDS Knowledge Base, HIV In Site, 1998(November 1998).Google Scholar
  17. 17.
    Frisch, M., et al., Sexually transmitted infection as a cause of anal cancer [see comments]. N Engl J Med, 1997. 337(19): p. 1350–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Feigal, E., Second National AIDS Malignancy Conference, National Institutes of Health, May 1998, Bethesda, MD. Jo Acquired Immune Deficiency Syndromes, 1999. 21: Suppl 1 p. s2-s4.Google Scholar
  19. 19.
    Northfelt, D.W., P.S. Swift, and J.M. Palefsky, Anal neoplasia: Pathogenesis, diagnosis, and management. Hematol Oncol Clin North Am, 1996. 10(5): p. 1177–87.PubMedCrossRefGoogle Scholar
  20. 20.
    Palefsky, J.M., Anal squamous intraepithelial lesions: relation to HIV and human papillomavirus infection. J Acquir Immune Defic Syndr, S42–8.Google Scholar
  21. 21.
    Friedman, H.B., et al. Human papillomavirus, anal squamous intraepithelial lesions, and human immunodeficiency virus in a cohort of gay men. J Infect Dis, 1998. 178(1): p. 45–52.PubMedCrossRefGoogle Scholar
  22. 22.
    Daling, J.R., et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med, 1987. 317(16): p. 973–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Vernon, S.D., Holmes, K.K. and Reeves, W.C. Human papillomavirus infection and associated disease in persons infected with human immunodeficiency virus. Clin Infect Dis, 1995. 21 Suppl 1: p. S121–4.PubMedCrossRefGoogle Scholar
  24. 24.
    Sillman, F.H. and Sedlis, A. Anogenital papillomavirus infection and neoplasia in immunodeficient women. Obstet Gynecol Clin North Am, 1987. 14(2): p. 537–58.PubMedGoogle Scholar
  25. 25.
    Pfister, H., Relationship of papillomaviruses to anogenital cancer. Obstet Gynecol Clin North Am, 1987. 14(2): p. 349–61.PubMedGoogle Scholar
  26. 26.
    Gal, A.A.,. Saul, S.H and Stoler, M.H. In situ hybridization analysis of human papillomavirus in anal squamous cell carcinoma. Mod Pathol, 1989. 2(5): p. 439–43.PubMedGoogle Scholar
  27. 27.
    Palefsky, J.M., et al., Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer. Cancer Res, 1991. 51(3): p. 1014–9.PubMedGoogle Scholar
  28. 28.
    Richart, R. and B. Barron, A Follow-UP Study of Patients with Cervical Dysplasia. Am J Obstet Gynecol, 1969. 105: p. 386–393.PubMedGoogle Scholar
  29. 29.
    Campion, M.J., et al., Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study. Lancet, 1986. 2(8501): p. 237–40.PubMedCrossRefGoogle Scholar
  30. 30.
    Penn, I., Cancers of the anogenital region in renal transplant recipients. Analysis of 65 cases. Cancer, 1986. 58(3): p. 611–6.PubMedCrossRefGoogle Scholar
  31. 31.
    Penn, I., Tumors of the immunocompromised patient Annu Rev Med, 1988. 39: p. 63–73.Google Scholar
  32. 32.
    Biggar, R. Cancers in AIDS: What Types and What Clues to Etiology? in National AIDS Malignancy Conference. 1998. Bethesda, MD.Google Scholar
  33. 33.
    Melbye, M., et al., High incidence of anal cancer among AIDS patients. The AIDS/Cancer Working Group. Lancet, 1994. 343(8898): p. 636–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Williams, A B, et al., Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Obstet Gynecol, 1994. 83(2): p. 205–11.PubMedGoogle Scholar
  35. 35.
    Palefsky, J.M., et al., Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol, 1998. 17(4): p. 320–6.PubMedCrossRefGoogle Scholar
  36. 36.
    Palefsky, J., Holly, E. and Ralston, M. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency (HIV)-positive and HIV- negative homosexual men. J Infect Dis, 1998. 177: p. 361–367.PubMedCrossRefGoogle Scholar
  37. 37.
    Hillemanns, E., Ellerbrock, T. and McPhillips, S. Prevalence of anal human papillomavirus infection and anal cytologic abnormalities in HIV-seropositive women. AIDS, 1996. 10: p. 1641–1647.PubMedCrossRefGoogle Scholar
  38. 38.
    Kurman, R. and Solomon, D. The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses: Definitions, Criteria, and Explanatory Notes for Terminology and Specimen Adequacy. 1994, New York: Springer-Verlag.Google Scholar
  39. 39.
    Palefsky, J.M., Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an emerging problem [editorial]. AIDS, 1994. 8(3): p. 283–95.PubMedCrossRefGoogle Scholar
  40. 40.
    Jay, N., et al., Colposcopic appearance of anal squamous intraepithelial lesions: relationship to histopathology. Dis Colon Rectum, 1997. 40(8): p. 919–28.PubMedCrossRefGoogle Scholar
  41. 41.
    de Ruiter, A., et al., A comparison between cytology and histology to detect anal intraepithelial neoplasia. Genitourin Med, 1994. 70(1): p. 22–5.PubMedGoogle Scholar
  42. 42.
    Palefsky, J.M., et al., Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol, 1997. 14(5): p. 415–22.PubMedCrossRefGoogle Scholar
  43. 43.
    Palefsky, J.M., et al., High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. Aids, 1998. 12(5): p. 495–503.PubMedCrossRefGoogle Scholar
  44. 44.
    Palefsky, J.M., et al., Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol, 1998. 17(4): p. 314–9.PubMedCrossRefGoogle Scholar
  45. 45.
    Palefsky, J., Papillomavirus-Associated Neoplasias and HAART. Third National AIDS Malignancy Conference, Bethesda, MD, 1999. Abstract 13.Google Scholar
  46. 46.
    DeVita, V., Hellman, S. and Rosenberg, S. Cancer: Principles and Practice of Oncology. 5th ed. 1997, Philadelphia: Lippincott and Raven.Google Scholar
  47. 47.
    Wexner, S.D., Milsom, J.W. and Dailey, T.H. The demographics of anal cancers are changing. Identification of a high-risk population. Dis Colon Rectum, 1987. 30(12): p. 942–6.PubMedCrossRefGoogle Scholar
  48. 48.
    Biggar, R.J. and Rabkin, C.S. The epidemiology of AIDS--related neoplasms. Hematol Oncol Clin North Am, 1996. 10(5): p. 997–1010.PubMedCrossRefGoogle Scholar
  49. 49.
    Palefsky, J. HPV-Associated Anogenital Neoplasia. in AIDS-Associated Malignancies. 1999. San Francisco, CA.Google Scholar
  50. 50.
    Lyter, D., Kingsley, L. and Rinaldo, C. Malignancies in the Multicenter AIDS Cohort Study. in Proceedings of ASCO. 1996.Google Scholar
  51. 51.
    Grulich, A.E., et al., Risk of cancer in people with AIDS. Aids, 1999. 13(7): p. 839–43.PubMedCrossRefGoogle Scholar
  52. 52.
    Rabkin, C.S., et al., Second primary cancers following anal and cervical carcinoma: evidence of shared etiologic factors. Am J Epidemiol, 1992. 136(1): p. 54–8.PubMedGoogle Scholar
  53. 53.
    Werness, B.A.,. Levine, A.J and Howley, P.M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science, 1990. 248(4951): p. 769.CrossRefGoogle Scholar
  54. 54.
    Dyson, N., et al., The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science, 1989. 243(4893): p. 934–7.PubMedCrossRefGoogle Scholar
  55. 55.
    Palefsky, J.M. and Holly, E.A. Molecular virology and epidemiology of human papillomavirus and cervical cancer. Cancer Epidemiol Biomarkers Prey, 1995. 4(4): p. 415–28.Google Scholar
  56. 56.
    Klencke, B. Invasive Anal Disease and Other non-AIDS Defining Neoplasms. in AIDS-Associated Malignancies. 1999. San Francisco, CA.Google Scholar
  57. 57.
    Goldie, S.J., et al., The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA, 1999. 281(19): p. 1822–9.PubMedCrossRefGoogle Scholar
  58. 58.
    Bartelink, H., et al., Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups [see comments]. J Clin Oncol, 1997. 15(5): p. 2040–9.PubMedGoogle Scholar
  59. 59.
    Lorenz, H.P., et al., Squamous cell carcinoma of the anus and HIV infection. Dis Colon Rectum, 1991. 34(4): p. 336–8.PubMedCrossRefGoogle Scholar
  60. 60.
    Holland, J. and Swift, P. Tolerance of Patients with Human Immunodeficiency Virus and Anal Carcinoma to Treatment with CombinedChemotherapy and Radiation Therapy. Radiology, 1994. 193: p. 251–254.PubMedGoogle Scholar
  61. 61.
    Peddada, A. Smith,D. and Rao, A Chemotherapy and Low-Dose Radiotherapy in the Treatment of HIV-Infected Patients with Carcinoma of the Anal Canal. Radiat Oncol Biol Phys, 1997.37: p. 1101–1105.CrossRefGoogle Scholar
  62. 62.
    Hoffman, R, et al., The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int J Radiat Oncol BioI Phys, 1999.44(1): p. 127–31.CrossRefGoogle Scholar
  63. 63.
    Doci, R,. Zucali, R and LaMonica, G. Primary Chemoradiation Therapy with Fluorouraciland Cisplatinfor Cancerof the Anus: Results in 35 Consecutive Patients. Journal of ClinicalOncology, 1996.14: p. 3121–3125.Google Scholar
  64. 64.
    Chadwick EG, et al. Tumors of smooth-muscle origin in HIV-infected children. JAMA 1990; 263: 3182–3184.PubMedCrossRefGoogle Scholar
  65. 65.
    Ha C HJ, Rollins NK.: Smooth muscle cell tumors in immunocompromised (HIV negative) children. Pediartr Radio 23:413–414, 1991CrossRefGoogle Scholar
  66. 66.
    Granovsky MO et al: Cancer in human immunodeficiency virus-infected children: a case series from the Children’s Cancer Group and the National Cancer Institute. J Clin Oncol 16:1729–1735, 1998PubMedGoogle Scholar
  67. 67.
    Levin TL, Adam HM, van Hoeven, KH, Goldman HS. Hepatic spindle cell tumors in HIV positive children. Pediatr Radiol 1994; 24:78–79.PubMedCrossRefGoogle Scholar
  68. 68.
    McCain L, Leach C, Jenson H, et al. Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl J MEd. 1995;332:12–18.CrossRefGoogle Scholar
  69. 69.
    Jenson HB et al: Benign and malignant smooth muscle tumors containing Epstein-Barr virus in children with AIDS. Leuk Lymphoma 27:303–314, 1997bGoogle Scholar
  70. 70.
    Jenson HB et al: Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma. J Med Viral 57:36–46, 1999CrossRefGoogle Scholar
  71. 71.
    Swanson PE, Deanna LP: Leiomyosarcoma of somatic soft tissues in childhood: an innumohistochemical analysis of six cases with ultrastructural correlation. Hu Pathol 22: 569–577, 1991.CrossRefGoogle Scholar
  72. 72.
    Miser JS, Triche TJ, Kinsella TJ et al. Other soft tissue sarcomas of childhood. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott-Raven Publishers, 1997:865–888.Google Scholar
  73. 73.
    Mueller, B. U. (1999). Cancers in Children Infected With the Human Immunodeficiency Virus. Oncologist 4: 309–317PubMedGoogle Scholar
  74. 74.
    Maize, J., Skin Cancer in Immunosuppressed Patients. JAMA, 1977. 237: p. 1857–1858.PubMedCrossRefGoogle Scholar
  75. 75.
    Penn, I., Immunosuppression and Skin Cancer. Clin Plast Surg, 1980. 7: p. 361–368.PubMedGoogle Scholar
  76. 76.
    Leigh, I., Buchanan, J. and Harwook, C. Role of Human Papillomavirus in cutaneous and Oral Manifestations of Immunosuppression. Jo Acquir Immunodeficiency Syndrome, 1999. 21S: p. S49–57.Google Scholar
  77. 77.
    Lobo, D., Chu, P. and Grekin, R. Nonmelanoma Skin Cancers and Infection with the Human Immunodeficiency Virus. Arch Dermatology, 1992. 128: p. 623–627.CrossRefGoogle Scholar
  78. 78.
    Kind, G., VonRoenn, J. and Jansen, D. Human Immunodeficiency Virus Infection and Subsequent Melanoma. Ann Plast Surg, 1996. 37: p. 273–277.PubMedCrossRefGoogle Scholar
  79. 79.
    Ragni, M.V., et al., Acquired immunodeficiency syndrome-associated non-Hodgkin’s lymphomas and other malignancies in patients with hemophilia. Blood, 1993. 81(7): p. 1889–97.PubMedGoogle Scholar
  80. 80.
    Smith, K., Skelton, H. and Yeager, J. Cutaneous Neoplasms in a Military Population of HIV-1-Positive Patients. Military Medical Consortium for the Advancement of Retroviral Research. J Am Acad Dermatology, 1993. 29: p. 400–406.CrossRefGoogle Scholar
  81. 81.
    Wang, C., Brodland, D. and Su, W. Skin Cancers Associated with Acquired Immunodeficiency Syndrome. Mayo Clin Proc, 1995. 70: p. 766–772.PubMedCrossRefGoogle Scholar
  82. 82.
    Massi, D., Borgognoni, L. and Reali, U. Malignant Melanoma Associated with Human Immunodeficiency Virus Infection: A Case Report and Review of the Literature. Melanoma Research, 1998. 8: p. 187–192.PubMedCrossRefGoogle Scholar
  83. 83.
    Mauer, T., Christian, K. and Kerschmann, R. Cutaneous Squamous Cell Carcinoma in Human Immunodeficiency Virus-Infected Patients. A Study of Epidemiologic Risk Factors, Human Papillomavirus and p53 Expression. Archives Dermatology, 1997. 133: p. 577–583.CrossRefGoogle Scholar
  84. 84.
    McGregor, J., Newell, M. and Ross, J. Cutaneous Malignant Melanoma and Human Immunodeficiency Virus Infection: A report of Three Cases. Br J Dermatol, 1992. 126: p. 516–519.PubMedCrossRefGoogle Scholar
  85. 85.
    Pierceall, W., Goldberg, L. and Anantheswamy, H. Presence of HPV Type 16 DNA Sequences in Human Non-Melanoma Skin Cancers. J Invest Dermatol, 1991. 97: p. 880–884.PubMedCrossRefGoogle Scholar
  86. 86.
    Fiorino, A. and Atac, B. Paraproteinemia, Plasmacytoma, Myeloma and HIV Infection. Leukemia, 1997. 11: p. 2150–2156.PubMedCrossRefGoogle Scholar
  87. 87.
    Ng, V., Chen, C. and Hwang, K. The Clinical Significance of Human Immunodeficiency Virus Type-1-Associated Paraproteins. Blood, 1989. 74: p. 2471–2475.PubMedGoogle Scholar
  88. 88.
    Ng, V., B-Lymphocytes and Autoantibody Profiles in HIV Disease. Clin Rev in Allergy and Immunology, 1996.14: p. 367–383.Google Scholar
  89. 89.
    Briault, S., Courtois-Capella, M. and Duarte, F. Isotypy of Serum Monoclonal Immunoglobulins in Human Immunodeficiency Virus-Infected Adults. Clin Exp Immunol, 1988. 74: p. 182–184.PubMedGoogle Scholar
  90. 90.
    Fine, J., Lambin, P. and Derycke, C. Systematic Survey of Monoclonal Gammopathies in the Sera from Blood Donors. Transfusion, 1979. 19: p. 332–335.PubMedCrossRefGoogle Scholar
  91. 91.
    Kyle, R., Monoclonal Gammopathy of Undetermined Significance. Blood Reviews, 1994. 8: p. 135–141.PubMedCrossRefGoogle Scholar
  92. 92.
    Kyle, R., Monoclonal Gammopathy of Undetermined Significance: Natural History in 241 Cases. Am J Med, 1978. 64: p. 814–826.PubMedCrossRefGoogle Scholar
  93. 93.
    Kyle, R., “Benign” Monoclonal Gammopathy: A Misnomer. JAMA, 1984. 251: p. 1849–1854.PubMedCrossRefGoogle Scholar
  94. 94.
    Kyle, R., Diagnostic Criteria of Multiple Myeloma. Hematol Oncol Clinics of North America, 1992. 6: p. 347–357.Google Scholar
  95. 95.
    Koblin, B.A., et al., Increased incidence of cancer among homosexual men, New York City and San Francisco, 1978–1990. Am J Epidemiol, 1996. 144(10): p. 916–23.PubMedCrossRefGoogle Scholar
  96. 96.
    Lee, G., Foerster, J. and Lukens, J. Wintrobe’s Clinical Hematology. 10TH ed. Vol. 2. 1999, Philadelphia: Lippincott, Williams and Wilkins. 2763.Google Scholar
  97. 97.
    Rettig, M., Ma, H. and Vescio, R. Kaposi’s Sarcoma-Associated Herpesvirus Infection of Bone Marrow Dendritic Cells in Multiple Myeloma Patients. Science, 1997. 276: p. 1851–1854.PubMedCrossRefGoogle Scholar
  98. 98.
    Lallemand, F., Fritsch, L. and Cywiner-Golenzer, C. Multiple Myeloma in an HIV-Positive Man Presenting with Primary Cutaneous Plasmacytomas and Spinal Cord Compression. J Am Acad Denn, 1998. 39: p. 506–507.CrossRefGoogle Scholar
  99. 99.
    Kumar, S., Kumar, D., Schnadig, V. Plasma Cell Myeloma in Patients Who are HIV-Positive. Am J Clin Pathol, 1994. 102: p. 633–639.PubMedGoogle Scholar
  100. 100.
    Bataille, R. and Harousseau, J. Multiple Myeloma. N Engl J Med, 1997. 336: p. 1657–1664.PubMedCrossRefGoogle Scholar
  101. 101.
    Ng, V. and McGrath, M. The Immunology of AIDS-Associated Lymphomas. Immunological Reviews, 1998. 162: p. 293–298.PubMedCrossRefGoogle Scholar
  102. 102.
    Konrad, R., Kricka, L. and Goodman, D Brief Report: Myeloma-Associated Paraprotein Directed Against the HIV-1 p24 Antigen in an HIV-1 Seropositive Patient. N Engl J Med, 1993. 328: p. 1817–1819.PubMedCrossRefGoogle Scholar
  103. 103.
    Lane, H., Masur, H. and Edgar, V Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency Syndrome. N Engl J Med, 1983. 309: p. 453–458.PubMedCrossRefGoogle Scholar
  104. 104.
    Breen, E., Rezai, V and Nakajima, K. Infection with HIV is Associated with Elevated IL-6 Levels and Production. J Immunol, 1990. 144: p. 480–484.PubMedGoogle Scholar
  105. 105.
    Kedes, D. Viral Oncogenesis in KS and its Therapeutic Implications. in AIDS-Associated Malignancies: Biology and Clinical Management. 1999. San Francisco, CA.Google Scholar
  106. 106.
    Gold, J., Schwam, L. and Castella, A. Malignant Plasma Cell Tumors in Human Immunodeficiency Virus-Infected Patients. Cancer, 1990. 66: p. 363–368.PubMedCrossRefGoogle Scholar
  107. 107.
    Shokunbi, W., Okpala, M. and Shokunbi, O. Multiple Myeloma Co-Existing with HIV-1 Infection in a 65-Year-Old Nigerian Man. AIDS, 1991. 5: p. 115–116.PubMedCrossRefGoogle Scholar
  108. 108.
    Rodriguez, J., Pereira, A. and Martinez, J. Pleural Effusion in Multiple Myeloma. Chest, 1994. 105: p. 622–624.PubMedCrossRefGoogle Scholar
  109. 109.
    Biggar, R.J., et al., Risk of other cancers following Kaposi’s sarcoma: relation to acquired immunodeficiency syndrome. Am J Epidemiol, 1994. 139(4): p. 362–8.PubMedGoogle Scholar
  110. 110.
    Petruckevitch, A., et al., Risk of cancer in patients with HIV disease. London African HIV/AIDS Study Group. Int J STD AIDS, 1999. 10(1): p. 38–42.PubMedCrossRefGoogle Scholar
  111. 111.
    Wingo, P., Tong, T. and Bolden, S. Cancer Statistics. CA Cancer J Clin, 1995. 45: p. 8–30.PubMedCrossRefGoogle Scholar
  112. 112.
    Sridhar Virus. Chest, K., Flores, M. and Raub, W. Lung Cancer in Patients with Human Immunodeficiency Virus. Chest, 1992. 102: p. 1704–1708.PubMedCrossRefGoogle Scholar
  113. 113.
    Alshafie, M., Donaldson, B. and Oluwole, S. Human Immunodeficiency Virus and Lung Cancer. Journal of Surgery, 1997. 84: p. 1068–1071.Google Scholar
  114. 114.
    Aaron, S., Warner, E. and Edelson, J. Bronchogenic Carcinoma in Patients Seropositive for Human Immunodeficiency 1994. 106: p. 640–642.Google Scholar
  115. 115.
    Johnson, C., Wilcosky, T. and Kvale, P. Cancer Incidence Among an HIV-Infected Cohort. Pulmonary Complications of HIV Infection Study Group. Am J Epidemiology, 1997. 146: p. 470–475.CrossRefGoogle Scholar
  116. 116.
    Tenholder, M. and Jackson, H. Bronchogenic Carcinoma in Patients Seropositive for Human Immunodeficiency Virus. Chest, 1993. 104: p. 1049–1053.PubMedCrossRefGoogle Scholar
  117. 117.
    Peyrade, F., Taillan, B. and Pradier, C. Lung Cancer in Patients Infected with Human Immunodeficiency Virus. Clinical Course and Therapeutic Implications. Presse Med, 1998. 27: p. 198–201.PubMedGoogle Scholar
  118. 118.
    Northfelt, D., Other Neoplasms Associated with HIV Disease, 1998.Google Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Phoebe Trubowitz
    • 1
  • Amy Gates
    • 1
  • Lawrence Kaplan
    • 1
  1. 1.University of CaliforniaSan Francisco General HospitalSan Francisco

Personalised recommendations